IL4 and breast cancer: Similarly, the number of migrated HUVECs increased by 10-fold (p < 0.001), 12-fold (p < 0.001), and 15-fold (p < 0.001), respectively, when cocultured with MDMs activated by IL-4, MDA-MB-231, or primary breast cancer cells (Figure 2A).